Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Nov 2 - Nov 7
Accessing Weight Loss Solutions in Alabama Although Retatrutide is exciting, it is not yet available
To view a copy of this license, visit About this article Cite this article Franchina, D.G., Kurniawan, H., Grusdat, M
From there, your clinician explains GLP-1 and GIP optionsSemaglutide, Tirzepatide, and any advanced agents offeredthen recommends a customized plan that includes dosing, follow-up schedule, and lifestyle support. One of our experts will review your medical history, current medications, lifestyle, and weight loss history
These are not subjective standards
1042 Cross-Cultural Adaptation and Psychometric Validation of the Danish and Norwegian Versions of the Steroid Symptom Questionnaire for Multiple Myeloma (SSQ-MM) Tine Rosenberg 1 , Claudia Rutherford 2 , Tracy King 3 , Margaret-Ann Tait 2 , Frida Bugge Askeland 4 , Lene Kongsgaard Nielsen 1 1 Quality of Life Research Center, Department of Hematology, Odense University Hospital, Odense, Denmark, 2 Cancer Care Research Unit, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia, 3 Clinical Research Fellow, Cancer Care Research Unit, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia, 4 Institute of Clinical Medicine, University of Oslo, Oslo, Norway Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :1042 Aims To translate and culturally adapt the Australian developed Steroid Symptom Questionnaire for Multiple Myeloma (SSQ-MM) into Danish and Norwegian and to evaluate the psychometric properties of the Norwegian version in newly diagnosed patients with MM
US$ 20.97
US$ 26.37
US$ 21.93
US$ 23.68
US$ 25.86
